Bloomberg -- When Deborah Dunsire took over as chief executive officer at Millennium Pharmaceuticals in 2005, the Cambridge (Mass.) company had only one drug on the market—the blood-cancer treatment Velcade—and sales growth was slowing.
Bloomberg -- When Deborah Dunsire took over as chief executive officer at Millennium Pharmaceuticals in 2005, the Cambridge (Mass.) company had only one drug on the market—the blood-cancer treatment Velcade—and sales growth was slowing.
